JP2023522229A5 - - Google Patents
Info
- Publication number
- JP2023522229A5 JP2023522229A5 JP2022563917A JP2022563917A JP2023522229A5 JP 2023522229 A5 JP2023522229 A5 JP 2023522229A5 JP 2022563917 A JP2022563917 A JP 2022563917A JP 2022563917 A JP2022563917 A JP 2022563917A JP 2023522229 A5 JP2023522229 A5 JP 2023522229A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- amino acid
- acid sequence
- sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010320420.3A CN113527486B (zh) | 2020-04-21 | 2020-04-21 | 一种抗Nectin-4的抗体及其应用 |
| CN202010320420.3 | 2020-04-21 | ||
| PCT/CN2021/088661 WO2021213434A1 (zh) | 2020-04-21 | 2021-04-21 | 一种抗Nectin-4的抗体及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522229A JP2023522229A (ja) | 2023-05-29 |
| JP2023522229A5 true JP2023522229A5 (cg-RX-API-DMAC7.html) | 2024-05-01 |
| JP7813721B2 JP7813721B2 (ja) | 2026-02-13 |
Family
ID=78094041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563917A Active JP7813721B2 (ja) | 2020-04-21 | 2021-04-21 | Nectin-4に対する抗体及びその用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12590150B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4141029A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7813721B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230007406A (cg-RX-API-DMAC7.html) |
| CN (2) | CN113527486B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021260639A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022021322A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3176385A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022013163A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021213434A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114845740B (zh) | 2020-01-31 | 2026-06-02 | 先天制药公司 | 癌症的治疗 |
| CN113527486B (zh) * | 2020-04-21 | 2025-12-02 | 迈威(上海)生物科技股份有限公司 | 一种抗Nectin-4的抗体及其应用 |
| AU2021276616A1 (en) * | 2020-05-20 | 2023-01-05 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 and uses thereof |
| JP2024501121A (ja) * | 2020-11-25 | 2024-01-11 | イナート・ファルマ・ソシエテ・アノニム | 癌の処置 |
| AU2022267613A1 (en) * | 2021-04-30 | 2023-11-23 | Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. | Antibody-drug conjugate targeting nectin-4 and preparation method therefor and use thereof |
| KR20240136924A (ko) * | 2021-08-27 | 2024-09-19 | 씨에스피씨 메가리스 바이오파마슈티칼 씨오., 엘티디. | 항 Nectin-4 항체, 약물 접합체 및 이의 제조방법 및 용도 |
| CN116478279A (zh) * | 2021-12-31 | 2023-07-25 | 武汉瑞法医疗器械有限公司 | 乙型肝炎病毒表面抗原纳米抗体吸附剂及制备方法和应用 |
| CN114702589B (zh) * | 2022-04-27 | 2022-11-01 | 博际生物医药科技(杭州)有限公司 | 治疗癌症的组合物和方法 |
| CN114702588B (zh) * | 2022-04-27 | 2022-11-22 | 博际生物医药科技(杭州)有限公司 | 抗Nectin-4抗体和双特异性抗体 |
| CN116063498A (zh) * | 2022-04-27 | 2023-05-05 | 博际生物医药科技(杭州)有限公司 | 单域抗Nectin-4抗体 |
| AU2023273063A1 (en) * | 2022-05-16 | 2024-11-14 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Pharmaceutical composition containing anti-nectin-4 antibody drug conjugate and use thereof |
| JP2025523049A (ja) * | 2022-07-14 | 2025-07-17 | バイオ-テラ ソリュ-ションズ,エルティーディー. | 抗Nectin-4抗体及びその使用 |
| CN115368463B (zh) * | 2022-07-19 | 2025-12-19 | 合肥天港免疫药物有限公司 | 双特异性抗体及其应用 |
| EP4324849A1 (en) * | 2022-08-18 | 2024-02-21 | Emergence Therapeutics AG | Humanized anti-nectin-4 antibodies |
| IL318911A (en) * | 2022-09-20 | 2025-04-01 | Nectin Therapeutics Ltd | Humanized antibodies against NECTIN-4 and their drug conjugates |
| US20260174868A1 (en) * | 2022-10-28 | 2026-06-25 | Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. | Preparation containing anti-nectin-4 antibody drug conjugate and use thereof |
| CN115877008A (zh) * | 2022-12-05 | 2023-03-31 | 中国科学院自动化研究所 | 用于膀胱癌检测的光学分子成像探针及其制备方法和应用 |
| JP2026508244A (ja) * | 2023-02-22 | 2026-03-10 | ナンジング リーズ バイオラブズ シーオー., エルティーディー. | 抗Nectin-4抗体及びそれを含む多重特異性抗体 |
| CN118871132A (zh) * | 2023-02-27 | 2024-10-29 | 石药集团巨石生物制药有限公司 | 重组人源化抗Nectin-4单抗-MMAE偶联药物的药物组合物 |
| CN116381251B (zh) * | 2023-03-13 | 2024-06-25 | 柏定生物工程(北京)有限公司 | 一种肿瘤标志物诊断试剂盒及其诊断方法 |
| CN119490590A (zh) * | 2023-05-24 | 2025-02-21 | 深圳市先康达生命科学有限公司 | 靶向人Nectin4蛋白的抗体或其片段和应用 |
| EP4725964A1 (en) * | 2023-06-08 | 2026-04-15 | Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. | Antibody binding to nectin-4 and use thereof |
| CN119390781B (zh) * | 2023-08-04 | 2026-04-17 | 湖南中晟全肽生物科技股份有限公司 | 特异性结合Nectin-4的多肽及其用途 |
| EP4534101A1 (en) | 2023-10-02 | 2025-04-09 | Eli Lilly and Company | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload |
| WO2025148933A1 (zh) * | 2024-01-08 | 2025-07-17 | 上海橙帆医药有限公司 | 抗体及其药物偶联物和用途 |
| CN117964682A (zh) * | 2024-01-12 | 2024-05-03 | 杭州爱科瑞思生物医药有限公司 | Dolastatin衍生物及其制备方法和应用 |
| CN120383674A (zh) * | 2024-01-26 | 2025-07-29 | 鲁南新时代生物技术有限公司 | 一种Nectin-4抗体及其应用 |
| WO2025162492A1 (zh) * | 2024-01-29 | 2025-08-07 | 甘李药业股份有限公司 | 一种连接子、配体-药物偶联物及其医药用途 |
| WO2025195487A1 (zh) * | 2024-03-21 | 2025-09-25 | 石药集团巨石生物制药有限公司 | 靶向Nectin-4的抗体药物缀合物的用途 |
| CN117986367B (zh) * | 2024-04-02 | 2024-07-16 | 上海美迪西生物医药股份有限公司 | 靶点为Nectin-4的抗体及其应用 |
| WO2025222063A2 (en) * | 2024-04-17 | 2025-10-23 | Marengo Therapeutics, Inc. | Multifunctional molecules binding to tcr and uses thereof |
| KR20250177512A (ko) * | 2024-06-14 | 2025-12-24 | 삼성바이오에피스 주식회사 | 신규한 항-넥틴-4 항체 및 이의 용도 |
| WO2026008043A1 (zh) * | 2024-07-04 | 2026-01-08 | 石药集团巨石生物制药有限公司 | 靶向Nectin-4的抗体药物缀合物和免疫检查点抑制剂联合的用途 |
| WO2026057016A1 (en) * | 2024-09-12 | 2026-03-19 | LaNova Medicines Limited | Anti-nectin-4 antibodies and conjugates thereof |
| CN119930825B (zh) * | 2025-02-13 | 2026-08-07 | 哈尔滨医科大学 | 一种Nectin-4靶向的纳米抗体及其在制备治疗膀胱癌的产品中的应用 |
| CN120271712B (zh) * | 2025-04-18 | 2026-08-07 | 哈尔滨医科大学 | 靶向Nectin-4的纳米抗体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080268476A1 (en) * | 2004-05-12 | 2008-10-30 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nectin 4 (N4) as a Marker for Cancer Prognosis |
| EP2067791A4 (en) * | 2006-10-06 | 2009-11-25 | Takeda Pharmaceutical | PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST CANCER |
| WO2011112566A2 (en) * | 2010-03-11 | 2011-09-15 | Abbott Laboratories | Basigin binding proteins |
| EP3347048B1 (en) * | 2015-09-09 | 2020-04-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies having specificity to nectin-4 and uses thereof |
| KR20190014525A (ko) * | 2016-05-27 | 2019-02-12 | 애브비 바이오테라퓨틱스 인크. | 면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질 |
| CN109810039B (zh) | 2017-11-22 | 2021-11-12 | 迈威(上海)生物科技股份有限公司 | 一种用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途 |
| US11274160B2 (en) | 2017-03-02 | 2022-03-15 | INSERM (Institut National de la Santé et de la Recherche Médicale | Antibodies having specificity to Nectin-4 and uses thereof |
| TWI870338B (zh) | 2017-06-05 | 2025-01-21 | 美商艾澤西公司 | 粘附分子-4結合蛋白及其使用方法 |
| US12077583B2 (en) * | 2018-05-09 | 2024-09-03 | Nectin Therapeutics Ltd. | Antibodies specific to human NECTIN4 |
| CN113527486B (zh) * | 2020-04-21 | 2025-12-02 | 迈威(上海)生物科技股份有限公司 | 一种抗Nectin-4的抗体及其应用 |
-
2020
- 2020-04-21 CN CN202010320420.3A patent/CN113527486B/zh active Active
-
2021
- 2021-04-21 EP EP21791797.0A patent/EP4141029A4/en active Pending
- 2021-04-21 CN CN202180030277.7A patent/CN115427452B/zh active Active
- 2021-04-21 AU AU2021260639A patent/AU2021260639A1/en active Pending
- 2021-04-21 JP JP2022563917A patent/JP7813721B2/ja active Active
- 2021-04-21 MX MX2022013163A patent/MX2022013163A/es unknown
- 2021-04-21 KR KR1020227040582A patent/KR20230007406A/ko active Pending
- 2021-04-21 CA CA3176385A patent/CA3176385A1/en active Pending
- 2021-04-21 WO PCT/CN2021/088661 patent/WO2021213434A1/zh not_active Ceased
- 2021-04-21 BR BR112022021322A patent/BR112022021322A2/pt unknown
- 2021-04-21 US US17/996,403 patent/US12590150B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6333882B2 (ja) | 抗体−薬剤コンジュゲート | |
| JP2023179713A5 (cg-RX-API-DMAC7.html) | ||
| JP2022101693A5 (cg-RX-API-DMAC7.html) | ||
| CN111587124A (zh) | Ror1抗体免疫缀合物 | |
| JP2019146572A5 (cg-RX-API-DMAC7.html) | ||
| JP2022506072A5 (cg-RX-API-DMAC7.html) | ||
| US11008400B2 (en) | Anti-5T4 antibodies and antibody-drug conjugates | |
| JP2020525542A5 (cg-RX-API-DMAC7.html) | ||
| JP2021509823A5 (cg-RX-API-DMAC7.html) | ||
| JP2009522329A (ja) | 線維芽細胞活性化タンパク質に特異的な抗体分子及びそれを含む免疫複合体 | |
| CN110022903B (zh) | Met抗体药物缀合物 | |
| JP7607564B2 (ja) | Pmel17に対する抗体及びその結合体 | |
| JP2012522513A5 (cg-RX-API-DMAC7.html) | ||
| JP2024501121A5 (cg-RX-API-DMAC7.html) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| IL305954A (en) | Nectin-4 protein antibody and extacan compounds | |
| CN110483639A (zh) | 靶向axl的抗体及抗体-药物偶联物及其制备方法和用途 | |
| WO2023104188A1 (en) | Anti-cdh6 antibodies and antibody-drug conjugates thereof | |
| EP3504244A1 (en) | Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof | |
| JP2023509214A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525916A5 (cg-RX-API-DMAC7.html) | ||
| TW202317630A (zh) | 抗gfral抗體及其應用 | |
| JPWO2021251459A5 (cg-RX-API-DMAC7.html) | ||
| US20260021194A1 (en) | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload | |
| CN114450025A (zh) | 使用包含多重酪氨酸激酶抑制剂和免疫检查点抑制剂的组合治疗癌症 |